phasa scan tumour density





. arterial-dominant phase, or when an isodense tumour in unenhanced scan . changes on CT scans. Hepatic nodules with high density or positive enhancement in arterial-dominant phase of .
. techniques, the portal venous phase was used for the tumor density . computed tomography (CT) scan shows large hepatic masses on a late arterial-phase image with hyperdense tumor .
. CT) scans occurs more frequently. This exploratory analysis investigated tumor density as a surrogate endpoint of sunitinib activity in a phase II HCC study.
The mean attenuation value of the nodular HCCs on triple-phase helical CT scans was . digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density.
. in a phase II HCC study. Experimental Design: Patients received sunitinib 50 mg/d (4 weeks on/2 weeks off). Tumor size and density were assessed on CT scans by .
The number of detected lesions was calculated in each phase. The density of the liver and tumor was . MDCT scan in the liver has optimized the protocol of arterial phase scan.
At 15 months, on CT scan, tumor density has started to increase again (Fig. 1D), phasa scan tumour density without . CT scan (arterial phase) showing liver, peritoneal, and soft tissue metastasis from .
phase scans (Figure 2, A and B). Dynamic CT showed a heterogeneously enhanced tumor . will show a low-density tumor with fat attenua tion and enhancement of the tumor with con
. boundaries, to tissue of equal density, such as mediastinum, chest wall or diaphragm. A boundary between tumor and normal
phasa scan tumour density
tissue may be clearly visible on any individual phase scan.
measuring the density of fatty tumor components, e.g. inangiomyolipomas.
original: speeduncau blunbosma peograhen giogratnens